First oral diabetes treatment for cats receives FDA approval
The product bexagliflozin (Bexacat; Increvet Inc) is also the first new FDA-approved SGLT2 inhibitor animal drug for all animal species. FDA officials have approved the first new oral drug for animals to improve glycemic control in otherwise healthy cats with diabetes mellitus that have not been previously treated with insulin. Bexagliflozin tablets (Bexacat; Increvet Inc) …
First oral diabetes treatment for cats receives FDA approval Read More »
